Meet our doctors Last reviewed: 19 Jun 2026 Sources Mounjaro KwikPen 10mg solution for injection in pre-filled pen SmPC, emc [accessed 25 May 2026] Once-Weekly Semaglutide in Adults with Overweight or Obesity, The New England Journal of Medicine (NEJM) [accessed 25 May 2026] Ozempic SmPC, emc [accessed 25 May 2026] Rybelsus 3 mg, emc [accessed 25 May 2026] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, NEJM [accessed 25 May 2026]
Some of the secondary gains are enhanced muscle mass and lean body composition, which can increase libido and sexual performance
Patients are seeing truly incredible results where other treatments and medications have failed
According to GoodRx, 88% of patients who still have coverage for GLP-1 agonists will face additional requirements to access them
If harmful drinking patterns emerge, a referral to appropriate behavioral health services can be valuable
If you were to buy into the marketing hype around GLP-1 drugs like Wegovy and Zepbound, you might believe they are a panacea for every patient who needs to lose weight, regardless of BMI
